Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Biotech companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Eli Lilly. FDA records under its name, each linked to the record. See the Eli Lilly group view.
As of Nov 14, 2026, FDA's public records list ImClone Systems with 1 drug application.
Drug applications: 1
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
Payments to Doctors (Open Payments)
What this company reported paying US doctors and teaching hospitals each year; see every company
2024: $0.5MGeneral $0.4M · Research $0.0M
2023: $0.4MGeneral $0.4M · Research $0.0M
2022: $0.2MGeneral $0.2M · Research $0.0M
2021: $0.3MGeneral $0.3M · Research $0.0M
2020: $0.3MGeneral $0.2M · Research $0.1M
2019: $0.2MGeneral $0.2M · Research $0.0M
Orphan Designations (FDA)
2 designations since 1983, 1 approved for the designated use, matched by the sponsor's name; see all orphan designations
cetuximabTreatment of pancreatic cancer · Jun 15, 2007
ErbituxTreatment of squamous cell cancer of the head and neck in patients who express epidermal growth… · Jul 3, 2000 · approved Mar 1, 2006
Names and Identifiers
Appears as
IMCLONE
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
